From left to right: Nick Spittal, Velocity COO, Justin Goodarz, VCT CCO, Dr. Mitchell Efros, VCT CEO From left to right: Nick Spittal, Velocity COO, Justin Goodarz, VCT CCO, Dr. Mitchell Efros, VCT CEO DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation ...

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ResearchAndMarkets.com's offering. Every biotech product is an amalgam of multiple raw materials that add purpose and efficiency to it. Since raw materials are the foundation of these products, it is important to have regulatory norms in place for them. Hence, this seminar discusses raw material compliance to ensure every fi ...

Electric vehicle (EV) giant Tesla (TSLA) reported fourth-quarter 2024 earnings per share of 73 cents, which missed the Zacks Consensus Estimate of 75 cents but increased from the year-ago figure of 71 cents. Total revenues of $25.71 billion also lagged the consensus mark of $27.5 billion but inched up from $25.17 billion recorded in the corresponding quarter of 2023.Stay up-to-date with the quarterly releases: See Zacks Earnings Calendar.Despite the significant miss, shares of Tesla were up more than 4% in ...

Paragon 28, Inc. (FNA) shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.2% gain over the past four weeks.Paragon 28 recorded a strong price rise on investors’ optimism surrounding an announcement by Zimmer Biomet to acquire all of the outstanding shares of Paragon 28. Zimmer Biomet agreed to buy Paragon 28 for an equity value of approximately $1.1 billi ...

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Analytical Method Validation, Verification and Transfer Virtual Seminar" training has been added to ResearchAndMarkets.com's offering. In this Analytical Method Validation Training Course, the overall recommendation for the purpose of the logical features for diverse types of authentication measures is highlighted for the examination of the drug substance and drug product. The trainees will be required to pay attention to the influences to reflect for confirma ...

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Verification and Validation - Product, Equipment/Process, Software and QMS" training has been added to ResearchAndMarkets.com's offering. This seminar will provide valuable assistance to all regulated companies that need to review and modify their Master Validation Planning and Plan(s). While this information is focused on Medical Devices, its principles apply to personnel/companies in the Pharmaceutical, Diagnostic, and Biologics fields. Develop/review a comp ...

ROCKVILLE, Md., Jan. 30, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced data from its RGX-121 (clemidsogene lanparvovec) program for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, will be shared at the 21st Annual WORLDSymposium™ 2025, taking place in San Diego, CA February 3-7, 2025. The following presentations include an encore of the topline results from the pivotal phase of the Phase I/II/III CAMPSIITE® trial of RGX-121. Abstract Title: Audiol ...

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Commercial Beverage Dispenser Equipment Market by Technology, Beverage Type, Material, Dispenser Type, End User, and Region 2025-2033" report has been added to ResearchAndMarkets.com's offering.The global commercial beverage dispenser equipment market size reached USD 7.2 billion in 2024. Looking forward, the market is projected to reach USD 10.7 billion by 2033, exhibiting a growth rate (CAGR) of 4.6% during 2025-2033. Continual technological developments and ...

Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Biostatistics for the Non-Statistician Training Course" training has been added to ResearchAndMarkets.com's offering.Learn clinical biostatistics course for the Non-Statistician The objective of this seminar is to provide every trainee with the information and skills that are mandatory to comprehend numerical concepts and answers as smears to scientific study and to positively convey the information to others. Statistics is a valuable tool that is good and use ...

The Estee Lauder Companies Inc. (EL) is likely to register a decline in its top and bottom lines when it reports second-quarter fiscal 2025 earnings on Feb. 4. The Zacks Consensus Estimate for net sales is pegged at almost $4 billion, suggesting a decrease of 6.9% from the prior-year quarter's level.The consensus mark for fiscal second-quarter earnings has remained unchanged in the past 30 days at 32 cents per share, indicating a decline of 63.6% from the figure reported in the year-ago quarter. EL has a tr ...